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ABS TRACT
Heart disease and type 2 diabetes are commonly believed to be rare among contemporary subsistence-
level human populations, and by extension prehistoric populations. Although some caveats remain, evi-
dence shows these diseases to be unusual among well-studied hunter-gatherers and other subsistence
populations with minimal access to healthcare. Here we expand on a relatively new proposal for why these
and other populations may not show major signs of these diseases. Chronic infections, especially hel-
minths, may offer protection against heart disease and diabetes through direct and indirect pathways. As
part of a strategy to insure their own survival and reproduction, helminths exert multiple cardio-protective
effects on their host through their effects on immune function and blood lipid metabolism. Helminths
consume blood lipids and glucose, alter lipid metabolism, and modulate immune function towards Th-2
polarization—which combined can lower blood cholesterol, reduce obesity, increase insulin sensitivity,
decrease atheroma progression, and reduce likelihood of atherosclerotic plaque rupture. Traditional
cardiometabolic risk factors, coupled with the mismatch between our evolved immune systems and
modern, hygienic environments may interact in complex ways. In this review, we survey existing studies
in the non-human animal and human literature, highlight unresolved questions and suggest future dir-
ections to explore the role of helminths in the etiology of cardio-metabolic disease.
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Introduction
Cardiovascular disease (CVD) accounted for 23% of
all deaths in the USA in 2014, with at least half of
these due to coronary artery disease (CAD), and an-
other 5% to stroke [1]. Prevalence of type 2 diabetes
mellitus (T2DM), which shares lifestyle and meta-
bolic risk factors with CVD, is also rising in the USA
and worldwide, and one-third of Americans are pro-
jected to have T2DM by 2050 [2, 3]. Although T2DM
itself is a major health epidemic [3], it is often co-
morbid with heart disease [4]. Although these
chronic causes of morbidity and mortality are highly
prevalent in industrialized populations, it is com-
monly believed by the public and specialists alike
that these diseases were rare or absent throughout
human evolutionary history. These afflictions of
industrialized society are often viewed as classic ex-
amples of an evolutionary mismatch due to rapid
environmental and lifestyle changes (‘moderniza-
tion’) outpacing our evolved genetic heritage.
According to this view, the widespread prevalence
of CVD and T2DM today result from our being ‘Stone
Agers in the fast lane’ [5]. In this review, we evaluate
this notion, and then amend traditional views about
the relevance of ancestral lifestyle factors on CVD
and T2DM by exploring the role of our ‘old
friends’—helminths [6].
Among past and contemporary hunter-gatherers,
CVD and T2DM risk factors like obesity, hyperten-
sion, hypercholesterolemia and insulin resistance
appear to be rare. Epidemiological surveys from
the mid-20th century among! Kung hunter-gatherers
[7], Central African pygmies [8], Australian abori-
gines [9], South African Bantu [10–12], Pacific
Islanders [13, 14] and other rural, subsistence-level
populations with minimal exposure to market
economies [15, 16] support the notion that these risk
factors are rare, and suggest that changes in diet,
physical activity, other behaviors (e.g. smoking, al-
cohol consumption) and psychosocial stress alters
the health of such populations in ways predicted by
the mismatch hypothesis. Indeed, an experiment in
the 1980s where ‘Westernized’ diabetic Australian
aborigines were reintroduced to a traditional
hunter-gatherer diet and lifestyle for seven weeks
showed improvements in metabolic condition,
including lower fasting glucose, triglycerides, blood
pressure and weight loss [17, 18].
It is commonly believed that prehistoric humans
might not have suffered from CAD, T2DM and other
chronic diseases of aging because lifespans were
short throughout most of human history, and be-
cause CAD and T2DM are not implicated as major
causes of old age mortality. While old age mortality
is certainly lower today (and modal ages of death
about a decade longer) [19], there is no evidence that
diseases like CAD and T2DM only exist today be-
cause of longer lifespans. Despite low life
expectancies, hunter-gatherers and farming popula-
tions with limited access to medical care are likely to
reach middle age and older adulthood if they survive
early childhood. High infant and child mortality
brings calculations of life expectancy at birth (e0)
to 21–37 years for hunter-gatherer populations; how-
ever, given survival to age 15, the modal age of death
for hunter-gatherers, farmers and even 18th century
Europeans ranges from 68 to 78 years [20]. Thus, if
CAD and T2DM are chronic diseases of aging uni-
versally expressed in all populations, then their
manifestations should be readily observable among
older members of subsistence-level societies.
Despite suggestive findings that CAD, T2DM and
their risk factors are largely absent among contem-
porary pre-industrial populations, several consider-
ations caution against concluding that these
diseases represent a purely modern disease process,
and are therefore absent in remote populations
practicing traditional lifeways. First, computed
tomographic (CT) scans of mummies spanning
4000 years from Egypt, Peru, the American
Southwest and Aleutian Islands show evidence of
probable or definite calcific atherosclerosis, and
not just among well-fed elites [21]. The Tyrolean ice-
man (5300 y BP) of central Europe also exhibited
calcification of both carotid arteries, the aorta and
iliac artery [22]. Such calcifications are predictive of
fatal vascular events in modern populations [23].
Second, the apparent absence of CAD and T2DM
in extant populations could be due to methodo-
logical and logistic limitations. Given the demo-
graphic structure of most extant pre-industrial
populations, sample sizes of older adults are small
and subject to mortality bias, limiting statistical
power and inference. Third, if case fatality rates are
high among those afflicted with CAD and T2DM in
the absence of healthcare, then cross-sectional sur-
veys are unlikely to capture the short-lived cases,
such as survival post-myocardial infarction (MI).
Even the axiomatic claim that Greenland Inuit were
free of atherosclerosis [e.g. 24] has been contested
due to problematic mortality statistics [25]. Fourth,
most studies of CAD and T2DM in remote popula-
tions focus on easily measured symptoms like blood
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pressure, blood lipid levels and anthropometrics ra-
ther than diagnosis from direct measures of athero-
sclerosis, which require greater technological
sophistication, such as electrocardiogram (ECG)
and CT, or detailed information on causes of
mortality.
Yet even with these considerations in mind,
converging evidence (see ‘case studies of cardio-
metabolic disease in contemporary preindustrial
human societies’ section) supports the early epi-
demiological surveys cited above and suggests
that hunter-gatherers, horticulturalists and agro-
pastoralists living under relatively traditional condi-
tions do not experience CAD or T2DM. While more
technologically sophisticated analyses and longitu-
dinal data may suggest otherwise in the future, it
seems unlikely that clinically relevant CAD or
T2DM were ever frequent causes of morbidity and
mortality among older adults in pre-industrialized
societies. Lifestyle factors such as lean, high fiber
diets free of processed foods, higher physical activ-
ity, minimal smoking and other behaviors are pro-
tective factors common to many preindustrial
societies [5, 26]. Another important attribute com-
mon to these populations is the relatively high preva-
lence of diverse, frequently co-occurring infections
[27]. To date, the cardio-protective role of infection
against CAD or T2DM has not been seriously con-
sidered with rigorous studies. In fact, many infec-
tions can increase localized and systemic
inflammation and are thereby believed to increase
risk of CAD and T2DM, given epidemiological evi-
dence linking inflammation to these conditions in
industrialized populations [28–31]. Consistent with
this notion, the reduction in infectious disease dur-
ing epidemiological transitions of the past century
not only reduced period mortality of older adults, but
also reduced onset and fatality of chronic diseases
including CVD among cohort survivors [32, 33].
On the other hand, certain infections may have
cardio-protective effects, either directly or indirectly
through their effects on immune function and blood
lipid metabolism (Fig. 1). Intestinal helminths are
lipophilic and absorb lipids either from their host’s
gut contents or blood stream, either of which could
reduce their host’s circulating lipids and thereby
minimize accumulation of plaques in vasculature
[36]. Additionally, endo-parasites like helminths rep-
resent a significant energetic cost from immune ac-
tivation that increase resting metabolic rates, further
limiting adipose tissue deposition [37, 38]. These
helminths were likely a prevalent source of infection
over human evolutionary history. Their relative ab-
sence in modern, urban populations has likely
contributed not only to the growing prevalence
of auto-immune conditions associated with the ‘hy-
giene’ and ‘old friends’ hypotheses [6, 39], but may
also contribute to aberrant inflammation and im-
mune dysregulation that underlies many chronic
non-communicable diseases like CAD and T2DM.
Historically, in modern urban populations, the de-
cline in infections with improved public sanitation,
access to clean water and hygiene, and vaccines often
occurred concurrently with changes in diet, physical
activity and other lifestyle behaviors, making it diffi-
cult to tease apart the separate contributions of each
factor. Whether it is the absence of helminths alone,
or more likely, in combination with standard meta-
bolic risk factors like smoking, sedentary lifestyle and
hyper-caloric diet that has the largest effect on CAD
and T2DM progression remains to be determined. If
minimal CAD and T2DM in traditional populations
were only due to high physical activity, low choles-
terol, protective diet, minimal obesity and the ab-
sence of other well-known risk factors, then further
study of these populations as they undergo
socioeconomic transformation might not yield new
scientific discoveries that could ultimately benefit bio-
medicine. However, if helminths and other infections
have cardio-protective roles, then new insights will be
gained by focusing on populations currently under-
represented in biomedical research.
In this review, we first discuss the role of inflam-
mation and immune activation in CAD and T2DM
etiology and progression (‘The critical role of inflam-
mation in cardio-metabolic disease’ section), since
one key pathway by which infections can alter risk is
through immune system modulation. We next de-
scribe the role of helminths and other infections in
human populations (‘Infections and human evolu-
tion’ and Harmful effects of infection and CAD
T2DM’ sections ), and several ways in which their
presence may mitigate CAD and T2DM (‘Cardio-
metabolic protective effects of helminth infec-
tion’section 5). We evaluate existing experimental
evidence from animal models and observational evi-
dence from four human populations living a trad-
itional lifestyle who have been studied intensively
(Orumo of Ghana, Flores of Indonesia, Tsimane of
Bolivia and Kitava of Trobriand Islands) (‘case
studies of cardio-metabolic disease in contemporary
preindustrial human societies’ section). Throughout
the paper we focus more on CAD than T2DM given
two recent reviews examining the role of helminths
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on T2DM [34, 35]. We conclude by proposing future
research directions for evolutionary medicine
(‘Future prospects’ section).
The Critical Role of Inflammation in
Cardio-Metabolic Disease
In addition to genetic risk factors and modifiable life-
style behaviors, the immune system has been increas-
ingly implicated in CVD and T2DM [40]. In particular,
recent attention has helped redefine atherosclerosis
as an inflammatory disease. Inflammation is the gen-
eric innate immune response to pathogens, damaged
cells, and other irritations, whose function is to com-
bat initial assault and to initiate tissue repair [40].
Acute inflammation occurs in response to bacterial
and viral infection, and injury. Repeat activation and/
or chronic inflammation over months or years can be
destructive to tissues and lead to fibrosis, a condition
more common in the presence of persistent disorders
like asthma, tuberculosis, chronic periodontitis and
hepatitis, rheumatoid arthritis and inflammatory
bowel disease. In urban environments, chronic low-
grade inflammation is prevalent among obese adults
with excess lipids in adipose tissue and the liver [41],
and among chronic smokers [42, 43]. Different
sources of inflammation may vary in their down-
stream effects on vascular plaque formation; ‘infec-
tion-induced’ inflammation, a prominent source of
inflammation in pre-industrial societies, may be less
relevant than chronic low-grade inflammation from
smoking, obesity and other processes (e.g. psycho-
social stress) in the development of atherosclerosis
[44, 45].
Inflammatory processes are implicated in all
stages of CAD and T2DM [46–48]. With respect to
Figure 1. Summary of mechanisms by which helminths affect CAD and T2DM. ‘Lipid and Glucose Metabolism’: Helminths promoting Th2 immune bias induce
systemic elevations in eosinophils and alternatively activated macrophages (AAMs or M2), especially in white adipose tissue. AAMs producing resistin-like
molecule alpha (REMa) inhibit adipogenesis, while increased anti-inflammatory cytokines (e.g. IL-10) downregulate pro-inflammatory cytokines, increasing
insulin sensitivity [34]. Together these factors reduce obesity and insulin resistance, lowering risk of T2DM.Direct ‘Nutritional Costs of Helminths’: Helminths can
directly consume blood lipids, but may also decrease lipid levels by inhibiting their intestinal absorption, depending on species and density of infection. ‘Trade
Offs: Costs of Immune Function’: Immune activation is energetically expensive, and results in increased RMR, which can lead to less adipose storage, or possible
consumption of existing adipose tissue to generate eosinophils, macrophages and other immune components. ‘Classically Activated Macrophages (CAMs) and
LDL’: In hygienic populations, CAMs or M1 cluster at the site of arterial injuries and bind with LDL cholesterol, resulting in calcified lesions that progress with
repeated exposure. In presence of helminths, LDL is lower, and immunity is Th2-polarized with anti-inflammatory M2 macrophages recruited to fight infection; the
net effect is decreased atherosclerotic lesion progression. ‘Immune Modulation and Regulation and Atherosclerosis’: Th2-biased immunity increases AAMs and
regulatory T-cells, which release cytokines (IL-4, IL-5, IL-13, IL-10) that impact signaling pathways within adipose tissue (e.g. PPAR, STAT-6). T regulatory cells
inhibit Th-17 responses (e.g. IL-17), and produce other anti-inflammatory cytokines (e.g. IL-10) that result in immunomodulation disfavoring atherosclerotic
lesions, plaque vulnerability or insulin resistance [35]. Note: regular arrowhead suggests promotion, whereas flat arrowhead signifies inhibition
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CAD, the critical role of inflammation in mediating
the pathogenesis of atherosclerotic plaques and MI
has been well established for several decades, with
both innate and adaptive immunity responding to
self-antigens in the atheromatous plaque [49]. Most
of these self-antigens are considered to be derived
from trapped Apolipoprotein-B, oxidized LDL and
lipoprotein remnants in the sub-endothelial intima,
which accumulate in high velocity areas of arterial
branching and when plasma LDLs are high [49, 50].
Indeed, immune cells such as macrophages, T cells,
dendritic cells, and mast cells are all known to infil-
trate atherosclerotic plaques [51]. Plaque antigens
stimulate recruitment of monocytes from the blood
to pass through the arterial endothelium and form
macrophages to engulf the lipids that then trans-
form into lipid-laden foam cells. The critical feature
of plaque formation is that the lesion does not re-
solve, but instead a pro-inflammatory environment
is created, which in turn recruits more monocytes,
and a lipid-rich necrotic core forms from dead
macrophages and other immune cells [52, 53].
Atherosclerosis is produced, both additively and in
interaction, by a lipid-rich systemic environment and
increased chronic, pro-inflammatory immune
activation.
Inflammation is also recognized in the etiology of
insulin resistance, metabolic syndrome and T2DM
[54–58]. Consistent with the causal etiology
described above, prospective studies show that high
levels of inflammatory biomarkers such as high sen-
sitivity C-reactive protein (hs-CRP), interleukin-6 (IL-
6) and tumor necrosis factor alpha (TNF-a) are
related to CAD onset, progression and CAD-related
mortality [59–63]. Similarly, hs-CRP and other in-
flammatory biomarkers predict onset and progres-
sion of obesity, metabolic syndrome and T2DM [46].
In population-based studies, such as the Multi-
Ethnic Study of Atherosclerosis, Atherosclerosis
Risk in Communities and West of Scotland
Coronary Prevention Study (WOSCOPS), inflamma-
tory markers (e.g. IL-6, CRP), are strongly associated
with diabetes risk [64–67]. A recent meta-analysis
confirms the consistent dose-response relation-
ships between IL-6, CRP and diabetes risk [66, 68].
The effects of low-grade inflammation, as measured
through serum levels of various biomarkers in epi-
demiological studies, are largely independent of
more traditional risk factors like hypertension, obes-
ity and hypercholesterolemia, suggesting alternative
moderators (e.g. infection) influencing the link be-
tween inflammation, CAD and T2DM etiology.
Similarly, autoimmune conditions with excess in-
flammation such as rheumatoid arthritis, lupus,
and granulomatosis are also risk factors for athero-
sclerosis [69].
Infection and Human Evolution
Throughout history, human populations were
exposed to an array of pathogens, many of which
were common to other wild primate species [70].
Ancestral humans may also have been exposed to
additional pathogens and parasites due to the con-
sumption of meat and fish [71]. Phylogenetic evi-
dence for several pathogens, including smallpox,
Plasmodium falciparum, and Mycobacteria tubercu-
losis suggests a pre-agricultural history of exposure
[see review in 72]. Sexually transmitted diseases also
likely have a long evolutionary history among
humans [73]. Antibodies to viral infections, such as
herpes simplex, Epstein-Barr and varicella-zoster
virus (VZV) have been documented in isolated
Amazonian groups, along with cytomegalovirus
(CMV), intestinal helminths, herpes simplex
viruses, hepatitis B and arboviruses [74, 75].
Strong evidence suggests that helminths have co-
existed with humans for millennia and represent a
major feature of early human disease ecology [see 76
for review]. Non-human primates are widely infected
with helminths, and infection with multiple species
of soil-transmitted intestinal parasites has been
documented in remote Amerindian populations
[76–78]. Macro-parasites such as Enterobius
vermicularis (pinworm) and hookworms (Necator
americanus and Ancylostoma duodenale) have been
discovered in coprolites from 7 to 10 kya [79, 80].
Throughout human history, helminths burdens have
likely fluctuated. For example, sedentism and prox-
imity to domesticated animals from the introduction
of agriculture may bring about a higher parasitic bur-
den [81, 82]. However, it is likely that until relatively
recently very few humans had no helminth exposure
whatsoever. Helminths have complex life cycles
within human hosts, passing through numerous
host tissues, and with intricate survival strategies
that involve not only thwarting host immunity, but
also competing with other helminths for host re-
sources and creating a favorable niche by host ma-
nipulation [83, 84]. This long history suggests that
human immune systems have co-evolved with hel-
minths and may occasionally produce maladaptive
outcomes under the novel conditions introduced in
recent human history.
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During the last 150 years, changes to the water
supply, sanitation and public health infrastructure
have lowered exposure to infectious diseases [85,
86], and immunizations and medical interventions
have further reduced the prevalence of infectious
diseases and their harmful impacts. Those changes
in pathogen exposure and treatment have been
accompanied by increased processed food con-
sumption, tobacco and other drug use, reduced
physical activity, higher rates of depression [87]
and lower fertility, all of which may have complex
effects on health outcomes.
Harmful Effects of Infection on CAD and
T2DM
Despite the unresolved causal role of systemic in-
flammation on CAD and T2DM risk [88, 89], there is
increasing evidence that infection can generate
localized inflammation in coronary arteries [28, 29,
90, 91]. There is also increasing evidence for the
roles that viral and bacterial pathogens play in the
etiology of atherosclerosis via inflammation [30, 92,
93]. An infectious organism can contribute to inflam-
mation within a blood vessel, either directly by in-
fecting vascular cells and activating innate immune
responses, or indirectly by inducing inflammation at
a nonvascular site such as the lungs in the case of
Chlamydia pneumoniae.
In support of the direct route, viruses such as
CMV, and bacteria such as Helicobacter pylori have
been found in human and mouse atherosclerotic
plaques [30]. Epidemiological studies also show an
association between infection and atherosclerosis.
For example, CAD is associated with the number of
positive serologies against common infections (e.g.
CMV, hepatitis A virus, HSV-1 and 2) after adjust-
ment for traditional CAD risk factors [94]. In a pro-
spective follow-up, individuals with five positive
exposures were six times as likely to have MI or die
than those with one exposure [95]. Other results,
however, are inconsistent with a causal link between
pathogen burden and atherosclerosis; clinical trials
focusing on patients with CAD are unable to dem-
onstrate long-term benefit to antibiotic interven-
tions against C. pneumoniae [96–98]. Another
possibility is that infections and immune activation
increase oxidative stress [99, 100], which damages
arterial epithelium, oxidizes lipids and leads to
plaque formation [101].
The role of infection in the etiology of T2DM also
has a growing body of support [102]. Hepatitis C
virus appears to be directly involved in the develop-
ment of insulin resistance [31, 103, 104]. Individuals
infected with H. pylori are also at greater risk of de-
veloping T2DM [105, 106], although causality has
not yet been established. Although H. pylori is
associated with a 2.7 fold increase in risk of develop-
ing T2DM, other infections such as HSV1, VZV,
CMV and T. gondii are not associated with increased
risk [106].
Cardio-Metabolic Protective Effects of
Helminth Infection
Despite the systemic pro-inflammatory environ-
ment fostered by some bacterial and viral infections,
other infections might offer protection against CVD
and T2DM. A number of animal models provide evi-
dence of protective effects of one type of parasitic
infection—helminths (see Table 1). These include
mostly intestinal geohelminths such as hookworm
and roundworm, but may also include water-borne
helminths such as schistosomes and insect-borne
filarial helminths such as Wuscheria bancrofti. The
notion that helminths in particular might offer pro-
tection against atherosclerosis was first proposed in
2005 by the Israeli physician, Eli Magen [124]. A
small but growing number of studies are leading to
productive directions for testing this hypothesis. For
example, in apoE2/2 mice infected with Schistosoma
mansoni, atherosclerotic lesions in the aortic arch
and brachiocephalic artery were reduced by half
compared to uninfected controls with the same diet
[107, but see 108]. Another study reported a 60%
reduction in aortic lesions in mice inoculated with
a glycoprotein (ES-62) secreted by the filarial nema-
tode Acanthocheilonema viteae [109]. Experimental
infection of mice with the nematode
Nippostrongylus brasiliensis lowered obesity and
blood lipid levels, increased anti-inflammatory and
immune regulatory activity, and improved insulin
sensitivity [110]. Other murine studies show similar
effects of helminths on a number of metabolic risk
factors relevant to both CAD and T2DM [35, 108,
111, 112].
Several studies show similar associations in
humans (Table 1). Reports include minimal clinical
atherosclerosis in patients with schistosomal hep-
atic fibrosis [113], lower levels of T2DM with lymph-
atic filariasis [114], and lower blood glucose,
glycated hemoglobin (HbA1c), insulin resistance,
triglycerides and LDL with prior Schistosomiasis
japonicum infection [115]. The Indonesian
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ImmunoSPIN project, detailed in ‘Ende of Flores
Island’ section, has found that helminth infections
are associated with greater insulin sensitivity [116].
An autopsy study of 319 cadavers in the Khanty-
Mansiisk region of Russia measured both
Opisthochis felineus worm burden and area of athero-
sclerotic lesions in the thoracic and aortic arteries
[117]. Fatty streaks, fibrotic plaques and complicated
lesions were inversely related to the number of
worms per infected liver and were most common
in uninfected individuals.
Below we outline several possible routes,
summarized in Figure 1, by which helminths could
be associated with lower CAD and T2DM risk.
Blood lipids and energy restriction
Intestinal helminths are known to reduce energy in-
take and to be associated with anemia, poor nutri-
tional status and micro-nutrient malabsorption
[125–127]. In addition to interfering with host nutri-
tion through altering consumption and absorption,
helminths can also affect blood glucose and lipid
levels directly. Many pathogens rely on blood glucose
for energy [128, 129] and pathogen-induced immune
activation is costly, requiring significant increases in
resting metabolic rate and glucose utilization [38,
130, 131]. Increasing evidence suggests that host
lipids are manipulated by, and allocated to patho-
gens. Helminths may regulate host lipid metabolism
by stimulating a decrease in total cholesterol levels
[107], particularly low-density lipoprotein (LDL) and
Apolipoprotein B [132]. Several mechanisms may ac-
count for these decreases. Lipids mediate and are
used by innate immune responses [133]. Helminths
and protozoans (e.g. giardia) cannot synthesize their
own lipids, and so consume and metabolize host
lipids to generate phospholipid membranes [132], ex-
ploiting the host lipidome for their own survival and
reproduction [84, 134, 135]. Other pathogens,
including bacteria such as H. pylori and M. tubercu-
losis also exploit host lipids for their own growth,
maintenance and signaling [136]. Similar findings
have been obtained for enteroviruses through differ-
ent mechanisms [137] and for dengue [138]. Parasitic
worms may also lower LDL levels by regulating innate
antibodies to cholesterol [132]. About one third of
LDL turnover is attributed to the effects of these nat-
urally occurring antibodies to cholesterol [139–141].
Relatively few studies have related infection to
blood lipid levels. A variety of blood lipids (total chol-
esterol, LDL, very low-density lipoproteins (VLDLs), Ta
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high-density lipoproteins (HDLs), triglycerides), as
well as albumin and glucose, are lower in sheep in-
fected with the liver fluke Fasciola hepatica compared
with uninfected sheep [142]. In humans, an inverse
association between HDL-C and the density of infec-
tion by several parasitic worm species (hookworm,
Strongyloides stercoralis, Trichuris trichiura) was first
documented among Amazonian Shipibo of Peru
[118]. Hospital patients in Chandigarh, India, showed
lower HDL-C if infected with entamoebic and giardia
parasites [132]. Among elderly US Latinos, individuals
infected with CMV, HSV and VZV had lower LDL
(though not significantly) than their uninfected coun-
terparts [106]. Among Tsimane Amerindians [Box 2],
total cholesterol was 10 mg/dl lower among individ-
uals with elevated CRP and IL-6, and 19 mg/dL lower
among those with elevated IgE after controlling for age,
sex, body mass index (BMI) and hemoglobin [119].
New unpublished analyses further show that eosino-
phil counts are inversely associated with BMI, total
cholesterol, LDL, HDL, blood glucose and triglycer-
ides. Hookworm infection and higher eosinophil
counts are also associated with lower systolic BP.
Resting metabolic rate is also higher among adults
with active helminth infection [38].
Because oxidized LDL cholesterol is implicated in
inflammatory cascades leading to endothelial dys-
function, plaque maturation and rupture, some have
argued that heart attacks and other events
stemming from atherosclerosis would be rare if
LDL could be maintained <70 mg/dl [143].
However, the extent to which this low LDL level
could be achieved with an omnivorous diet in the
absence of parasites or statins is debatable.
Regulation and modulation of immune
function
One hypothesis linking parasitic infection to CAD
risk is that helminths may attenuate atherosclerosis
through interactions with host defenses [124].
Helminths do not simply evade host immune de-
fenses, but instead modulate and regulate immune
response in self-favoring ways to create niches that
optimize their own survival and reproduction.
Helminths increase anti-inflammatory T helper cell
(Th)-2 type responses, increasing eosinophils, IL-4,
and other Th-2 cytokines. Th-2 polarization induces
‘Alternative activation’ (or M2) macrophages,
whereas Th-1 polarization induces more ‘classical
activation’ (or M1) macrophages [144]. M1 macro-
phages are generated by pro-inflammatory factors
like IFN-g, or Toll-like receptor activation and secrete
cytokines and chemokines promoting inflammatory
responses. Polarized Th-2 immune activation
associated with helminth infection modifies cyto-
kine profiles, whereby anti-inflammatory IL-4, IL-10
and IL-13 protect vessel walls from oxidized LDL-
induced monocyte injury in the endothelium, and
downregulate fibrinogen synthesis [145]. Th-2 acti-
vation may also modulate responses to heat shock
proteins, C. pneumonia, and cytomegalovirus, and
downregulate monocyte activation, each of which
has been tentatively linked to atherosclerosis [124].
M2 macrophages are induced by IL-4 or IL-13 and
provide signals for tissue repair, wound healing and
fibrosis. Overall, helminths and their anti-inflamma-
tory effects are expected to reduce inflammation at
sites of vascular damage, inhibit LDL-induced
monocyte-endothelial damage, and thereby inhibit
atherosclerotic lesion formation, and potentially
subsequent plaque erosion and rupture.
Helminths also induce high levels of the antibody
immunoglobulin-E (IgE), which binds to Fc receptors
on surfaces of mast cells and basophils, and stimu-
lates Th-2 responses. Levels of total IgE are >160
times greater in non-Western human populations
which commonly experience helminth infection than
in the USA [146]. A recent case-control study showed
that adults with selective IgE deficiency (<2 IU/ml)
had higher rates of arterial hypertension, peripheral
vascular disease, ischemic heart disease, and carotid
stenosis than matched controls [147].
In addition to fostering anti-inflammatory activity,
helminths regulate Th-1 and Th-2 responses by
favoring greater regulatory T-cells which produce
down-modulatory cytokines IL-10 and TGF-b, and
other immune-modulatory mechanisms [148]. This
prevents clearance of the parasites by an immune sys-
tem that might otherwise operate at full potential [83].
Immune regulation may therefore reduce recursive in-
flammatory and autoimmune-like Th-1 responses
associated with many stages of atherosclerosis and
insulin resistance, and temper the collateral damage
of pro-inflammatory responses by fostering concomi-
tant anti-inflammatory activity.
Helminths have been linked to T2DM through
similar immune pathways. Mice infected with hel-
minths inducing eosinophilia, elevations in IL-4,
IL-13 and other cytokines associated with alternative
activation of macrophages (M2) in white adipose tis-
sue (e.g. IL-4, IL-13) show improved glucose tolerance
and reduced fat mass [110]. Mice fed high-fat diets in
the absence of helminths instead show greater M1
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macrophage activation (e.g. by IL-6, TNF-a), which
directly increased obesity, resistin release, and im-
paired glucose tolerance leading to greater insulin re-
sistance. Even with diet-induced obesity, the
eosinophilia and M2 macrophage activation in in-
fected mice helped maintain glucose homeostasis.
Though lipids were discussed separately (‘Blood
lipids and energy restriction’ section), the above de-
scription linking helminths to T2DM suggests much
complex cross-talk between immune and metabolic
pathways [149]. Macrophages and other immune cells
infiltrate white adipose tissue, promoting a pro-inflam-
matory state in the presence of obesity (the M1 pheno-
type). Adipokines, tissue inflammation and other
mechanisms beyond the scope of this review also im-
plicate adipose tissue as critical in shaping obesity-
induced peripheral insulin resistance. Inflammation-
mediated insulin resistance might be beneficial for
fueling immunity against acute bacterial infection,
but becomes pathological when ‘sterile’ chronic low-
grade inflammation is induced by obesity and other
non-infectious origins [150]. In addition, immune
modulation leading to Th-2 polarization may directly
affect lipids and their metabolism [151]. For example,
the redirection of lipids to immune function may result
in lower accumulation of self-antigens against LDL and
byproducts in the lumen and less immune activity dir-
ected towards those antigens. Consistent with this no-
tion, atherosclerotic lesions and cholesterol levels are
greater in Th-1 polarized mice deficient in Th-2 cytokine
IL-4 or STAT-6 transcription factor [152].
The recent characterization and recognition of
brown and beige adipose tissue has opened a new
area of study. Beige fat cell activation induces thermo-
genesis and increases metabolic rate, resulting in
weight loss and glucose homeostasis in mice, and
possibly in humans [150]. Eosinophils and Th-2 cyto-
kines are important for the biogenesis of beige or
brown fat, while the activation of these adipose tis-
sues is triggered by cold temperatures, exercise, and
possibly through other mechanisms including IL-33
[153, 154]. Although the complex interactions be-
tween immune function and adipocytes have not
yet been fully unraveled, there is growing evidence
that immune cells interact with adipose tissue to
modify glucose usage, lipid storage and metabolism.
Other mechanisms
Other possibilities exist beyond lipid consumption and
immune modulation. For example, parasites may divert
immune resources, particularly monocytes and
lymphocytes, towards infected tissues and away from
thearterial lumen,decreasing formationof fattystreaks,
fibrous plaques and complicated lesions. Suggestive of
this possibility, Tsimane have very low levels of mono-
cytes in circulation [37]. Along with the induction of a
strong Th-2 bias, helminths may divert resources away
from Th-1 type responses that aid in the continued
growth of atherosclerotic plaques. Calcium is also crit-
ical to signaling in immune and other cell responses
[155, 156], and chronic immune activation from infec-
tion may lower serum calcium, potentially resulting in
less calcification of arterial plaques (though such a con-
nection remains controversial) [157].
Living in a Poly-Parasitic World
An early version of the hygiene hypothesis proposed
that insufficient bacterial exposure in childhood af-
fecting Th-1 development can bias individuals to-
ward Th-2 mediated pathologies such as asthma
and allergies. It was later proposed that Th-2
stimulating ‘old friend’ parasites such as helminths
could help counteract Th-2 mediated pathologies by
leading to a better regulated immune network [39]. It
is likely that the combined suite of pathogens to
which the host is exposed determines whether the
net effect of infections is to delay or accelerate CAD
and T2DM. Populations with helminths often show
co-infection with multiple helminths inhabiting dif-
ferent tissues, and sometimes lower levels of giardia
and other pathogens [84]. Interactive effects with gut
microbiota are also likely to affect how helminths
modulate immunity. Gut microbiota have been
shown to be associated with energetic metabolism,
inflammation and obesity, and to metabolize pro-
atherogenic trimethylamine-N-oxide from red meat
[158] and eggs [159], and thus has also been invoked
as relevant to CAD and T2DM etiology [160]. Type 2
immunity provided by helminth infection inhibits in-
flammatory Bacteroides colonization and promotes
protective Clostridiales in mice [161], while helminth-
induced alteration of bacterial microbiota reduces
allergic asthma [162]. Subsistence populations show
a richer diversity of gut microbiota than market-
integrated populations [163, 164] and helminth in-
fections have been shown in one study to associate
with increased microbiota diversity [165]. Whether
these findings generalize to a broad range of popula-
tions remains to be seen, but it is likely that the joint
composition of both microbiota and macrobiota may
be important for maintaining host intestinal and im-
mune homeostasis [166]. The robust finding from
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recent research among subsistence populations
experiencing a greater diversity of pathogens shows
minimal evidence for CAD and T2DM, and no evi-
dence that higher levels of inflammation due to infec-
tion results in greater CAD and T2DM burden (see
‘case studies of cardio-metabolic disease in contem-
porary preindustrial human societies’ section).
One possibility is that having a greater diversity of
both Th-1 and Th-2 stimulating pathogens might
lead to less pathological relationships between cer-
tain infections and CVD, such as the oral pathogen
underlying periodontitis, Porphymonas gingivalis
[167]. Additionally, diet, exercise and metabolic fac-
tors likely interact with the suite of infections, and
resultant inflammation in affecting CVD and T2DM
risks. Inflammation may only be pro-atherogenic
and pro-diabetic in the context of excess energy, adi-
posity and high serum lipid levels, as is more com-
monly found in sedentary urban environments.
Case Studies of Cardio-Metabolic Disease
in Contemporary Preindustrial Human
Societies
Ende of Flores Island
In the rural and semi-urban Nangapanda area of
Flores Island, Indonesia, Maria Yazdanbakhsh,
Aprilianto Wiria and colleagues have studied the role
of helminths on immune function and chronic dis-
ease among Ende farmers as part of the
ImmunoSPIN project [116, 120, 168] (Fig. 2a).
Adults are relatively lean, but blood lipid levels and
blood pressure are high in comparison to other sub-
sistence-level populations (e.g. mean LDL is
123 mg/d; mean systolic/diastolic pressure: 130/
77 mmHg). Helminth infection (especially N.
americanus, A. lumbricoides, T. trichuris) is common,
and associated with higher IgE levels. They find that
helminths are associated with lower T2DM and CAD
risk factors. Those with helminth infection have
lower BMI, smaller waist-to-hip ratio, and lower
LDL and total cholesterol compared with uninfected
individuals (Fig. 3). Moreover, having more hel-
minth co-infections is associated with lower BMI,
WHR and total cholesterol among those infected.
Each additional helminth co-infection is associated
with 4.9 pmol/l lower insulin, independently of their
inverse relationship with BMI [116]. Higher IgE is
also associated with lower HDL, total cholesterol
and fasting blood glucose.
Tsimane of Bolivia
Tsimane are forager-horticulturalists of the Bolivian
Amazon (pop’n  16 000) studied by the Tsimane
Figure 2. Contemporary preindustrial study populations. (a) Three Ende women at a health clinic (Photo credit: Aprilianto Eddy Wiria). (b) Two elderly Tsimane
from a remote Tsimane village along the Maniqui River (Photo credit: Michael Gurven). (c) An older Bimoba woman in upper east Ghana (Photo credit: David van
Bodegom). (d) Elderly Kitava man and woman (Photo credit: Staffan Lindeberg). Note: all photos were obtained with permission and consent for use
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Health and Life History Project since 2002 (Fig. 2b).
Tsimane experience higher pathogen burden than
Western populations, including intestinal and vec-
tor-borne parasites, fungi, bacteria, viruses and
protozoa. They also show higher levels of immune
activation and inflammation, measured by white
blood cell counts, erythrocyte sedimentation rate,
CRP and IL-6 [169]. Eosinophilia (>500/ul) is abun-
dant (87%), as is monocytopenia (<2%) (93%) [37].
Systemic immunity shows indications of chronic ac-
tivation from parasitic infection, with serum im-
munoglobulins two orders of magnitude higher
than among US adults, including IgE; Tsimane
mean IgE is 10 719 (±251) IU/ml compared with
US reference ranges (<100 IU/ml).
Yet despite their pro-inflammatory state, there is
no robust evidence of MIs. A sample of 860 echo-
cardiograms of adults age 40–85 revealed only two
cases of possible MI, as evidenced by wall motion
abnormalities, and even those cases were con-
sidered dubious by the team of cardiologists that
found CT-based evidence of atherosclerosis in
human mummies (see ‘Introduction’ section). In a
sample of 350 ‘verbal autopsies’ using the 2012
WHO instrument [170], only one case suggestive
of MI was found, indicating that people in the U.S.
are more than 50 times more likely to die from MI
than Tsimane. In addition, hypertension is rare
among Tsimane, and most adults over age 40 show
no increase in blood pressure with age [171].
Tsimane also have very low prevalence of diabetes
(<1.5%). Levels of total cholesterol (TC) and LDL
are very low, with <2% of the population having
levels above typical clinical cut-offs for TC
(>240 mg/dl) or LDL (>130 mg/dl). This finding is
noteworthy because Tsimane adults are not very
lean, with 21% overweight (BMI between 25 and
30 kg/m2). Ongoing research relating infection to
CAD and T2DM progression has shown protective
effects on cholesterol, BMI and blood glucose (see
text, Fig. 4).
Bimoba of Ghana
The Bimoba, Kusasi, Mamprusi and Peul tribes of
the upper east region in Ghana are subsistence
farmers only recently undergoing an epidemiolo-
gical transition (Fig. 2c). Ongoing studies since
2001 by van Bodegom, Westendorp, Koopman,
and colleagues from Leiden University Medical
Center have reported that these groups inhabit an
infectious environment, rife with malaria, helminths,
typhoid fever, and protozoans; these have led to se-
lection for pro-inflammatory genotypes and strong
innate immune responses [172, 173]. Among adults
age 50+, CVD and T2DM risk factors are low: obesity
is rare (<2%) and dyslipidemia is low (1–5%), but
hypertension is somewhat prevalent (25%). T2DM
is also rare (1% have glucose > 7 mmol/l). Direct
evidence based on ECG and ultrasound measure-
ment of ankle-brachial blood pressure suggests min-
imal overt CVD: myocardial infarcts and peripheral
arterial disease are both rare (<1.2%, 2.8%, respect-
ively), as are both myocardial ischemia-like changes
and atrial fibrillation (11% and 0.3%, respectively) in
comparison to age-matched USA and European
comparison samples [174]. Although CVD and
T2DM are rare, and infection highly prevalent, direct
linkages between indicators of helminth infection
Figure 4. Relationships between indicators of infection and immune activation on blood lipids.
Sample of 418 adults age 20+ from 17 Tsimane villages in 2004, collected as part of the Tsimane
Health and Life History Project. Low hemoglobin, high CRP and IL-6, high IgE and eosinophil
count are all associated with lower total blood cholesterol, and to some extent with lower HDL
cholesterol. Results based on multiple regression analyses of total-C (n = 345) and HDL (n =
318) that also control for age, sex, BMI. Low Hb refers to first quartile, high eosinophils refers to
fourth quartile. Based on [119]
Figure 3. Difference in cardiometabolic risk factors between Ende infected (n = 446) and un-
infected (n = 229) with at least one soil-transmitted helminth. Cross-sectional representative
sample of adults age 18+ in a semi-urban area of Nangapanda on Flores Island were collected
from May to August 2009. Most prevalent helminths include N. Americanus, A. lumbricoides,
T. trichiura. Error bars are the 95% CI for the mean difference. Results are similar but attenuated
when adjusting for age, sex and BMI. Based on [120]
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and cardiometabolic health have not yet been
studied.
Kitava of Melanesia
The Kitava, subsistence horticulturalists of the
Trobriand Islands, have been studied by Staffan
Lindeberg, Johan Frostega˚rd and colleagues since
1990 (Fig. 2d). The Kitava are lean and have low
blood pressure and blood lipid levels [175].
Carbohydrates make up 69% of the diet, including
yams, sweet potatoes, taro and fruit; fat, salt, cereal
grain and dairy intake is low. ECGs and surveys re-
vealed no indications of heart attack, stroke or an-
gina pectoris, again suggesting that ischemic heart
disease was minimal or absent in this population
[176]. Plasminogen activator inhibitor-1 and other
risk factors for thrombosis are also low [177].
Older adults also do not appear to show worsening
age profiles of many CVD risk factors compared to
younger adults (e.g. BMI, plasminogen activator in-
hibitor 1) [178]. Serum insulin and glucose levels are
also low, especially among older adults, consistent
with favorable insulin sensitivity [179]. Lindeberg
and colleagues have argued that the physically active
Kitava lifestyle free of processed foods is largely re-
sponsible for the lack of CVD and T2DM.
Additionally, they suggest a possible relationship be-
tween infection and CVD based on serological evi-
dence of treponemal bacterial spirochetes. Anti-
treponemal IgM antibodies are highly prevalent
among Kitava and attributed to subclinical yaws dis-
ease [180]. Treponemal infection can induce IgM
autoantibodies to the epitope phosphorylcholine
(PC), which were observed at higher levels among
Kitava than a matched Swedish sample [181].
Because these anti-PC antibodies can inhibit uptake
of oxidized LDL in macrophages, the presence of
treponemal infection could be anti-atherosclerotic
[180, 181]. Helminths are also prevalent among
Kitava, but have not yet been investigated.
Future Prospects
We have proposed that helminths may offer protec-
tion against CAD and T2DM due to their modulatory
and regulatory effects on both immune function, and
other risk factors such as blood cholesterol levels,
metabolism and insulin resistance. Our focus on
immune dysregulation as a central feature of CAD
and T2DM is consistent with claims that atheroscler-
osis is an autoimmune disease [182]. Thus,
helminth-induced Th-2 stimulation, anti-inflamma-
tory activity, regulation and alternative macrophage
activation can offer important protection.
Over a billion people worldwide are infected with
at least one soil-transmitted helminth, though
prevalence is confined largely to lower income
countries lacking public health infrastructure [183].
Helminth eradication has therefore been a public
health target, aimed at improving child growth,
school performance and economic productivity,
and host defenses against other infections (e.g. mal-
aria, tuberculosis, HIV) [184]. The toll of helminth
infection on the average lifespan has been estimated
to be at least 4.7 disability-adjusted life years [183].
However, recognition that helminths may poten-
tially reduce morbidity from CAD and T2DM, and
other inflammatory diseases, should reduce this
estimated burden, and at the same time, deworming
campaigns could have harmful consequences later
in adulthood [185].
To date, descriptions of the effects of
‘Westernization’ on increasing CVD and T2DM risk
focus almost exclusively on changes in traditional
Framingham risk factors [e.g. 27, 185]. More re-
search is needed to better understand the varied
and intricate proximate mechanisms briefly outlined
above before developing interventions that could
mimic the effects of helminths but without any
harmful effects. There are many unanswered ques-
tions about how different helminths impact the host
responses described here, and others, such as
whether helminths influence all types of HDL
equally. Although a new infection or exposure to hel-
minth protein products may not reverse arterial cal-
cification or other chronic processes, indications
suggest that rapid changes in other CAD and
T2DM risk factors are possible. For example, the
Wu et al. [110] murine study described earlier
showed that a single infectious episode of up to only
eight days provoked sustained eosinophilia in adi-
pose tissue, lowered blood glucose, increased insu-
lin sensitivity and prevented excessive weight gain.
Golden hamsters injected with S. mansoni-derived
soluble egg antigen showed reduced blood choles-
terol, and atherosclerotic plaque size and progres-
sion, partly by reducing the number of inflammatory
monocytes, and reducing recruitment and accumu-
lation of myeloid cells in the plaques [121]. An on-
going clinical trial in Indonesia (SUGARSPIN) is
employing randomized double-blind, placebo-
controlled experiments to better test causal relation-
ships between helminths, insulin sensitivity and
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metabolic variables [187]. The mouse experiment
introducing the anti-inflammatory glycoprotein ES-
62 secreted by a filarial nematode that inhibited in-
flammation and protected against arthritis, asthma,
and atherosclerosis highlights another avenue of po-
tential intervention using helminth protein products
[109]. Ongoing clinical trials are using self-limiting
non-human parasites (e.g. Trichuris suis, a pig whip-
worm) or antigens from attenuated or inactivated
human parasites to treat autoimmune disorders
[188–190]. CAD and T2DM treatments based on
similar principles could be tested in the future.
Other important questions remain. It will be im-
portant to explore how helminth exposure early in
life versus adulthood might have differing conse-
quences of various aspects of immune function
and blood lipids, how duration of exposure affects
outcomes, and whether antigens or helminth-
derived products can substitute for live helminth in-
fection. Also, helminths may have different effects
on male versus female hosts. How helminths inter-
act with bacterial and fungal microbiomes is also
relatively unexplored but could have important con-
sequences on host immunity [191].
Another area of future research is to expand the
domain of genetic association studies. Amerindians
show distinct human leukocyte antigen (HLA) ex-
pression at various MHC loci compared with other
populations that show evidence of overdominant
selection [192]. Although HLA-DR expression in
macrophages and T-cells has been linked to plaque
eruption and erosion [193], it is an open question
whether allelic variation is of clinical significance.
Genes affecting monocyte recruitment (e.g. CD14
receptor polymorphisms) [194], lipid transport (e.g.
cholesteryl ester transport protein) [195], lipid oxida-
tion, and modulation of the inflammatory response
to oxidized lipids may also help explain differences
in susceptibility of populations to developing ath-
erosclerosis [196].
Conclusion
Although CAD and T2DM are major contributors to
mortality in urban populations, they may not have
been significant causes of adult morbidity and mor-
tality throughout most of human evolutionary his-
tory when infectious pathogens caused much of
mortality and when inflammation was largely patho-
gen-driven. Evidence from past and contemporary
subsistence-level populations suggests that CVD
and T2DM risk factors like obesity, hypertension,
hypercholesterolemia and insulin resistance are
rare. Although there is evidence of atherosclerosis
in HORUS studies of mummy CTs [21], these calci-
fications may not have had clinical symptoms severe
enough to result in hard events like stroke or heart
attack. Extant and historical subsistence popula-
tions may show evidence of arterial stiffening and
calcification, but lower likelihood of plaque erosion,
rupture and thrombosis. If subsistence-level popu-
lations were free of CAD and T2DM only because of
minimal obesity, greater physical activity, low hyper-
tension, low LDL and healthy diet, then we would
have little to learn from their continued study.
However, the relatively long co-evolutionary history
of helminths and other pathogens with humans
highlight potential mutualisms with beneficial ef-
fects on human health. Given the evidence
summarized here, the recognition that most bio-
medical studies rely on pathogen-free laboratory
models or pathogen-sparse Western populations
suggest that there is still much to learn about CAD
and T2DM etiology, progression, prevention and
treatment.
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